Annual Needham

 
News Articles for Annual Needham top ^
2013/4/25
CLEVELAND, April 25, 2013 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) announced today that Gil Van Bokkelen, Ph.D., Chairman and Chief Executive Officer, will present at the 12 th Annual Needham Healthcare Conference to be held at The Westin New York Grand Central from April 30 - May 1, 2013 in New York City.
Sign-up for Athersys to Present at 12th Annual Needham Healthcare Conference investment picks
2013/4/18
BioLineRx (NASDAQ: BLRX) (TASE: BLRX), a biopharmaceutical development company, announced today that its Chief Executive Officer, Kinneret Savitsky, Ph.D., and its Chief Financial and Operating Officer, Philip Serlin, will be presenting at the 12 th Annual Needham Healthcare Conference in New York.
Sign-up for BioLineRx to Present at the 12th Annual Needham Healthcare Conference in New York on April 30, 2013 investment picks
2013/5/30
AOL Inc. (NYSE: AOL) today announced that the CEO of its Brand Group, Susan Lyne, will participate in the 8 th Annual Needham Internet & Digital Media Conference on June 4, 2013, at the Westin Grand Central Hotel in New York City.
Sign-up for AOL Brand Group CEO Susan Lyne To Participate In 8th Annual Needham Internet & Digital Media Conference investment picks
2013/4/17
PhotoMedex, Inc. (NasdaqGS: PHMD) today announced that Dennis McGrath, president and chief financial officer, will present at the 12 th Annual Needham Healthcare Conference on Wednesday, May 1 st at 8:00 a.m. Eastern Time.
Sign-up for PhotoMedex, Inc. to Present at the 12th Annual Needham Healthcare Conference investment picks
2013/4/24
TORONTO, April 24, 2013 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, today announced that Shameze Rampertab, Vice President Finance and Chief Financial Officer, will present a Company overview at the 12 th Annual Needham Healthcare Conference at the Westin NY Grand Central Hotel in New York at 3:40pm EDT on Wednesday, May 1, 2013.
Sign-up for Intellipharmaceutics Announces Webcast of Presentation at the 12th Annual Needham Healthcare Conference investment picks
2013/4/25
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) , a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced that it will present at the 12 th Annual Needham Healthcare Conference on Tuesday, April 30, 2013, at 8:00 a.m. Eastern Time at The Westin New York Grand Central Hotel in New York City.
Sign-up for ACADIA Pharmaceuticals to Present at the 12th Annual Needham Healthcare Conference on April 30, 2013 investment picks
2013/4/29
Media Advisory - Oncolytics Biotech® Inc. to Present at 12th Annual Needham Healthcare Conference Canada NewsWire A live audio link to the webcast presentation is available at: http://wsw.com/webcast/needham58/oncy/ or on the company's website at www.oncolyticsbiotech.com/presentations .
Sign-up for Media Advisory - Oncolytics Biotech® Inc. to Present at 12th Annual Needham Healthcare Conference investment picks
2013/4/24
CHAPEL HILL, N.C. , April 24, 2013 /PRNewswire/ -- Cempra, Inc. (Nasdaq: CEMP) today announced that Prabhavathi Fernandes , Ph.D., president and chief executive officer of Cempra, will present at the 12 th Annual Needham Healthcare Conference at 1:40 p.m. EDT , Wednesday, May 1 , at the Westin New York Grand Central Hotel in New York .
Sign-up for Cempra, Inc. to Present at 12th Annual Needham Healthcare Conference investment picks
2013/4/24
SAN DIEGO , April 24, 2013 /PRNewswire/ --  Senomyx , Inc. (NASDAQ: SNMX) , a  company using proprietary taste science technologies to discover and develop novel flavor ingredients for the food, beverage, and ingredient supply industries, announced today that Kent Snyder , the Company's Chief Executive Officer, and John Poyhonen , President and Chief Operating Officer, will present an overview of the Company's technology and programs on Wednesday, May 1 , at 10:00 a.m. Eastern Time ( 7:00 a.m. Pacific Time ) during the 12 th Annual Needham Healthcare Conference.
Sign-up for SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE 12TH ANNUAL NEEDHAM HEALTHCARE CONFERENCE investment picks
2013/4/24
SEATTLE , April 24, 2013 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) , a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation, bleeding and disorders of the central nervous system, today announced that it will present at the 12 th Annual Needham Healthcare Conference next week.
Sign-up for Omeros to Present at the 12th Annual Needham Healthcare Conference investment picks
2013/4/23
BURLINGTON, Mass., April 23, 2013 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) is presenting at the 12th Annual Needham Healthcare Conference at the Westin Grand Central Hotel in New York, NY.
Sign-up for LeMaitre Vascular to Present at the 12th Annual Needham Healthcare Conference on April 30th investment picks
2013/4/23
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) , a leading RNAi therapeutics company, today announced that management will present a company overview at the 12 th Annual Needham Healthcare Conference on Tuesday, April 30, 2013 at 3:40 p.m. ET at the Westin Grand Central Hotel in New York City.
Sign-up for Alnylam to Webcast Presentation at 12th Annual Needham Healthcare Conference investment picks
2013/4/23
EAST RUTHERFORD, N.J. , April 23, 2013 /PRNewswire/ -- Cambrex Corporation (NYSE: CBM, "Cambrex") is pleased to announce that Steven Klosk , President and Chief Executive Officer, will make a presentation on the Company at the 12 th Annual Needham Healthcare Conference on April 30, 2013 at 8:00 a.m. EDT at the Westin Grand Central Hotel, New York City .
Sign-up for Cambrex To Present At The 12th Annual Needham Healthcare Conference investment picks
2013/4/25
Tetraphase Pharmaceuticals, Inc. (NASDAQ: TTPH) , a clinical-stage biopharmaceutical company developing a portfolio of potent new antibiotics designed to be effective against dangerous, drug-resistant bacteria (including multidrug-resistant (MDR) gram-negative pathogens), today announced that Tetraphase President & Chief Executive Officer Guy Macdonald will present at the 12th Annual Needham Healthcare Conference on Wednesday, May 1, at 11:20 a.m. Eastern Time.
Sign-up for Tetraphase Pharmaceuticals to Present at the 12th Annual Needham Healthcare Conference investment picks
2013/4/25
NEW YORK, April 25, 2013 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML) , a clinical-stage biopharmaceutical company developing oncology therapeutics that target both cancer stem cells (CSCs) and tumor bulk, announced today that Ivan Bergstein, M.D., Chief Executive Officer, will present at the 12th Annual Needham Healthcare Conference on Wednesday, May 1, 2013 at 11:20 am ET.
Sign-up for Stemline Therapeutics to Present at the 12th Annual Needham Healthcare Conference on May 1, 2013 investment picks
2013/4/15
IRVINGTON, N.Y., April 15, 2013 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (Nasdaq:MELA) , the medical device company that has developed and is commercizlizing MelaFind ® , today announced that it will be participating in the upcoming Needham Growth Conference, being held April 30 – May 1, 2013 at the Westin Grand Central Hotel in New York.
Sign-up for MELA Sciences to Participate in Upcoming 12th Annual Needham Healthcare Conference investment picks
2013/4/24
http://media.marketwire.com/attachments/200811/432392_conmed.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1010098&ProfileId=051205&sourceType=1 UTICA, NY --
Sign-up for CONMED Corporation to Present at the 12th Annual Needham Healthcare Conference investment picks
2013/4/25
http://media.marketwire.com/attachments/201211/99925_41732_threshold.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1010706&ProfileId=051205&sourceType=1 SOUTH SAN FRANCISCO, CA --
Sign-up for Threshold Pharmaceuticals Announces Presentation and Webcast at the 12th Annual Needham Healthcare Conference investment picks
2013/4/23
Pernix Therapeutics Holdings, Inc. (NASDAQ: PTX) , a specialty pharmaceutical company, today announced that Cooper Collins, President and Chief Executive Officer, will present at the 12 th Annual Needham Healthcare Conference on Tuesday, April 30, 2013 at 12:10 p.m. EST.
Sign-up for Pernix Therapeutics to Present at the 12th Annual Needham Healthcare Conference investment picks
2013/4/22
CARLSBAD, Calif.
Sign-up for Isis Pharmaceuticals to Present at the 12th Annual Needham Healthcare Conference investment picks

Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Annual Needham
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Annual National  |  Next: Annual Net